FDA Clearance Tracker · P010030-S162
LifeVest Wearable Defibrillator
Last checked: Nov 20, 2026Latest source record: Jun 30, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 30, 2023
Approved
Time to decision
206 days
Received Dec 6, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010030-S162
- Device name
- LifeVest Wearable Defibrillator
- Applicant
- Zoll Manufacturing Corporation
- Applicant location
- Pittsburgh, PA
- Received
- Dec 6, 2022
- Decided
- Jun 30, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010030
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the new generation model, LifeVest 5100, involving minor software, hardware and labeling changes.
Source documents
Other decisions for Zoll Manufacturing Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K190939 · Decided Dec 19, 2019 · 253 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
K182093 · Decided Jan 28, 2019 · 178 days after receipt
Device type: Electrocardiograph (DPS) · Cardiology
K172510 · Decided May 11, 2018 · 263 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.